{"id":36105,"date":"2021-08-13T15:13:00","date_gmt":"2021-08-13T13:13:00","guid":{"rendered":"https:\/\/www.ipsen.com\/press-releases\/ipsen-annonce-le-retrait-de-sa-demande-dapprobation-pour-le-palovarotene-et-son-intention-den-soumettre-une-nouvelle-apres-des-analyses-de-donnees-complementaires\/"},"modified":"2023-08-22T15:13:51","modified_gmt":"2023-08-22T13:13:51","slug":"ipsen-annonce-le-retrait-de-sa-demande-dapprobation-pour-le-palovarotene-et-son-intention-den-soumettre-une-nouvelle-apres-des-analyses-de-donnees-complementaires","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-annonce-le-retrait-de-sa-demande-dapprobation-pour-le-palovarotene-et-son-intention-den-soumettre-une-nouvelle-apres-des-analyses-de-donnees-complementaires\/","title":{"rendered":"Ipsen annonce le retrait de sa demande d\u2019approbation pour le palovarot\u00e8ne et son intention d\u2019en soumettre une nouvelle apr\u00e8s des analyses de donn\u00e9es compl\u00e9mentaires"},"content":{"rendered":"